The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BOPA 2017 | Mind the gap! Drug funding and access
The methods of how new medication is determined to be cost-effective serve a crucial role in drug access. Here, Ms Man-Chie Chow from the Royal Surrey County Hospital, Guildford, UK discusses the ‘Mind the gap! From the latest scientific advances in multiple myeloma to the reality of patient access in the UK’ talk at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK. Ms Chow focuses on the issue of drug funding, particularly for multiple myeloma, and the problems with the methods of analysis NICE employs to evaluate new additions to current treatments.
